SEARCH

SEARCH BY CITATION

REFERENCES

  • Adab N, Kini U, Vinten J, Ayres J, Baker G, Clayton-Smith J, Coyle H, Fryer A, Gorry J, Gregg J, Mawer G, Nicolaides P, Pickering L, Tunnicliffe L, Chadwick DW. (2004) The longer term outcome of children born to mothers with epilepsy. Journal of Neurology. Neurosurgery and Psychiatry 75:15751583.
  • Baram TZ. (2003) Long-term neuroplasticity and functional consequences of single versus recurrent early-life seizures. Annals of Neurology 54:701705.
  • Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, Dzietko M, Pesditschek S, Mai I, Dikranian K, Olney JW, Ikonomidou C. (2002) Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 99:1508915094.
  • Eikel D, Lampen A, Nau H. (2006) Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chem Res Toxicol 19:272278.
  • Farwell JR, Dodrill CB, Batzel LW. (1985) Neuropsychological abilities of children with epilepsy. Epilepsia 26:395400.
  • Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. (2004) Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 187:403409.
  • Grosso S, Franzoni E, Coppola G, Iannetti P, Verrotti A, Cordelli DM, Marchiani V, Pascotto A, Spalice A, Acampora B, Morgese G, Balestri P. (2005) Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 14:248253.
  • Hanon E, Klitgaard H. (2001) Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia. Seizure 10:287293.
  • Harris LW, Sharp T, Gartlon J, Jones DN, Harrison PJ. (2003) Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18:17061710.
  • Huang L, Cilio MR, Silveira DC, McCabe BK, Sogawa Y, Stafstrom CE, Holmes GL. (1999) Long-term effects of neonatal seizures: a behavioral, electrophysiological, and histological study. Brain Res Dev Brain Res 118:99107.
  • Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:7074.
  • Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, Olney JW, Wozniak DF. (2003) Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23:876882.
  • Johannessen SI, Battino D, Berry DJ, Bialer M, Kramer G, Tomson T, Patsalos PN. (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25:347363.
  • Katz I, Kim J, Gale K, Kondratyev A. (2007) Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494500.
  • Kim J. Kondratyev AD, Gale K. (2007) Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate and levetiracetam as monotherapy vs. polytherapy. J Pharmacol Exp Ther [Jul 16; Epub ahead of print.
  • Klitgaard H. (2001) Levetiracetam: the preclinical profile of a new class of antiepileptic drugs? Epilepsia 42(suppl 4):1318.
  • Kondratyev A, Sahibzada N, Gale K. (2001) Electroconvulsive shock exposure prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 91:113.
  • Koukkari MW, Guarino EJ. (2004) Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol 19:944947.
  • Lagae L, Buyse G, Ceulemans B. (2005) Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 14:6671.
  • Long L. (2003) Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 4:447448.
  • Manthey D, Asimiadou S, Stefovska V, Kaindl AM, Fassbender J, Ikonomidou C, Bittigau P. (2005) Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 193:497503.
  • Mares P, Maresova S, Maresova D. (1989) Antimetrazol action and plasma levels of valproate in developing rats. Physiol Bohemoslov 38:97107.
  • Marini H, Costa C, Passaniti M, Esposito M, Campo GM, Ientile R, Adamo EB, Marini R, Calabresi P, Altavilla D, Minutoli L, Pisani F, Squadrito F. (2004) Levetiracetam protects against kainic acid-induced toxicity. Life Sci 74:12531264.
  • Masco D, Sahibzada N, Switzer R, Gale K. (1999) Electroshock seizures protect against apoptotic hippocampal cell death induced by adrenalectomy. Neuroscience 91:13151319.
  • Olney JW. (2002) New insights and new issues in developmental neurotoxicology. Neurotoxicology 23:659668.
  • Olney JW, Young C, Wozniak DF, Ikonomidou C, Jevtovic-Todorovic V. (2004a) Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology 101:273275.
  • Olney JW, Young C, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. (2004b) Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 25:135139.
  • Perucca E, Johannessen SI. (2003) The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disord 5(suppl 1):S17S26.
  • Pucci V, Bugamelli F, Mandrioli R, Ferranti A, Kenndler E, Raggi MA. (2004) High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures. Biomed Chromatogr 18:3744.
  • Reinisch JM., Sanders SA, Mortensen EL, Rubin DB. (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274;15181525.
  • Schmid R, Tandon P, Stafstrom CE, Holmes GL. (1999) Effects of neonatal seizures on subsequent seizure-induced brain injury. Neurology 53:17541761.
  • Schmued LC, Hopkins KJ. (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123130.
  • Wheless JW, Ng YT. (2002) Levetiracetam in refractory pediatric epilepsy. J Child Neurol 17:413415.